← Back to headlines
Prothena Authorizes $100 Million Share Repurchase Plan
Prothena, a biotechnology company, has announced that its board of directors authorized a share repurchase program of up to $100 million.
27 Feb, 21:24 — 27 Feb, 21:24
ℹOnly 1 source covers this story
